Statistics
Publications
34
Citations
2.8K
H-Index
24
Active since
1968
Karl Kramer is an author at Technical University of Munich specializing in pharmacy, monoclonal antibodies, and biotechnology.
Publications per year
1968–2024
34
34
The target landscape of clinical kinase drugs
Susan Klaeger, Stephanie Heinzlmeir, Mathias Wilhelm et al. · Science · 2017 · 871 citations · Full text
Medicine, Oncology, Pharmacology +15
Martin J. Loessner, Karl Kramer, Frank Ebel et al. · Molecular Microbiology · 2002 · 370 citations · Full text
Life Sciences, Biology, Microbiology +17
Building ProteomeTools based on a complete synthetic human proteome
Daniel P. Zolg, Mathias Wilhelm, Karsten Schnatbaum et al. · Nature Methods · 2017 · 274 citations · Full text
Optimized Chemical Proteomics Assay for Kinase Inhibitor Profiling
Guillaume Médard, Fiona Pachl, Benjamin Ruprecht et al. · Journal of Proteome Research · 2015 · 136 citations
Decrypting drug actions and protein modifications by dose- and time-resolved proteomics
Jana Zecha, Florian Bayer, Svenja Wiechmann et al. · Science · 2023 · 118 citations · Full text
Medicine, Oncology, Pharmacology +15
1–5 of 34